LC3-lipidation-assay

Liv Jensen

Published: 2022-12-03 DOI: 10.17504/protocols.io.kqdg392ypg25/v1

Disclaimer

DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK

The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.

Abstract

Protocol for an in vitro LC3 lipidation assay using purified proteins and synthetic liposomes.

Steps

1.

Mix 2μM ATG3, 2μM ATG7, 1μM WIPI2, 200nM ATG12–ATG5-ATG16L1-GFP, 5μM LC3B

1:1 with extruded liposomes in reaction buffer.

2.

Incubate at 37 ̊C

3.

At 0, 15, 30, 60, and 120 minutes, remove 12μl of reaction mixture andquench by

adding 4ul of SDS-PAGE loading bufferandheatingat 60 ̊C for 10 minutes.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询